Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-01-001340
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSONJOHNSON & JOHNSON DEVELOPMENT CORPORATION

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G y45574sc13g.txt SC 13G 12140
  Complete submission text file 0000950123-01-001340.txt   14118
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7000 NORTH BROADWAY SUITE 400 DENVER CO 80221
Business Address 7000 NORTH BROADWAY SUITE 400 DENVER CO 80221 3034266262
ALLOS THERAPEUTICS (Subject) CIK: 0001097264 (see all company filings)

EIN.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60251 | Film No.: 1542035
SIC: 2834 Pharmaceutical Preparations